Article
Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at-risk groups.
Journal of pediatric gastroenterology and nutrition - 1 Mar 2012
Kurppa Kalle, Salminiemi Jaakko, Ukkola Anniina, Saavalainen Päivi, Löytynoja Katja, Laurila Kaija, Collin Pekka, Mäki Markku, Kaukinen Katri
Abstract excerpt
OBJECTIVE: Demonstration of small-bowel mucosal damage has been the basis of celiac disease diagnosis, but the diagnostic approach is undergoing changes. The European Society for Pediatric Gastroenterology, Hepatology, and Nutrition recently stated that in a subgroup of children, high positive transglutaminase 2 antibody (TG2ab) values may be sufficient for the diagnosis. The utility of these new criteria was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
